PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
11193379-14	2000	Similarly, dbcAMP inhibited the production of IFN-gamma and IL-2 more potently than that of IL-4 and IL-5.	Bucladesine	11-17	interleukin 2	Homo sapiens	60-64	
11602691-2	2001	Addition of dibutyryl cAMP mimicked rolipram inhibitions on proliferation, IL-2, TNF-alpha, and IFN-gamma but not on IL-10 or IL-5 production.	Bucladesine	12-26	interleukin 2	Homo sapiens	75-79	
10102795-7	1999	IL-2 production was also inhibited by dbcAMP in the presence of HA1004 and Rp-cAMPS.	Bucladesine	38-44	interleukin 2	Homo sapiens	0-4	
9502171-8	1998	Similarly, dbcAMP inhibited the production of IFN-gamma and IL-2 more potently than IL-4 and IL-5.	Bucladesine	11-17	interleukin 2	Homo sapiens	60-64	
8858999-5	1996	cAMP-elevating agents, such as PGE2, forskolin and dibutyryl cAMP, suppressed IL-2, IL-4 and IL-5 production by concanavalin A-stimulated PBMC in a manner similar to that of T-440.	Bucladesine	51-65	interleukin 2	Homo sapiens	78-82	
2175326-10	1990	In addition, we also demonstrate that NK cell cytotoxic activation induced by IL-2 is still demonstrable in the presence of Bt2cAMP under conditions in which NK cell proliferation is blocked.	Bucladesine	124-131	interleukin 2	Homo sapiens	78-82	
1333364-3	1992	The augmentative effect of dbcAMP in PBMC cultures was due to an increase in IL-2 production and not to increased in IL-2R-alpha chain expression.	Bucladesine	27-33	interleukin 2	Homo sapiens	77-81	
1333364-9	1992	Taken together, our results indicate that cAMP can play a positive regulatory role in T cell proliferation due to factor(s) secreted by dbcAMP-treated monocytes resulting in increased IL-2 synthesis in T cells.	Bucladesine	136-142	interleukin 2	Homo sapiens	184-188	
2473111-3	1989	Preincubation with dibutyryl-cAMP restored the ability of the truncated Ia expressing-transfectant to stimulate IL-2 release by otherwise nonresponsive T hybrids.	Bucladesine	19-33	interleukin 2	Homo sapiens	112-116	
6257625-5	1980	In addition, both L-isoproterenol and DBcAMP in the presence of theophylline decreased LK-induced macrophage aggregation, whereas D-isoproterenol and DBcGMP had no effect.	Bucladesine	38-44	interleukin 2	Homo sapiens	87-89	
2842097-2	1988	Dibutyryl cyclic AMP markedly suppressed NK, IL-2-augmented NK and ADCC activities in a dose-dependent manner but not previously induced LAK activity.	Bucladesine	0-20	interleukin 2	Homo sapiens	45-49	
6096309-2	1984	The addition of either N6,O2-dibutyryl cyclic AMP (DB-cAMP), aminophylline or isoproterenol to CTC cultures significantly suppressed the proliferation of CTC stimulated by either PHA or IL-2.	Bucladesine	23-49	interleukin 2	Homo sapiens	186-190	
6096309-2	1984	The addition of either N6,O2-dibutyryl cyclic AMP (DB-cAMP), aminophylline or isoproterenol to CTC cultures significantly suppressed the proliferation of CTC stimulated by either PHA or IL-2.	Bucladesine	51-58	interleukin 2	Homo sapiens	186-190